PepTalk 2017
PepTalk 2017
Pipeline Six Header

Cambridge Healthtech Institute’s Fourth Annual
Single-Use Technologies and Continuous Processing
Advancing Bioprocessing through Technological Innovation
January 9-10, 2017 | Hilton San Diego Bayfront | San Diego, CA


The steady adoption of single-use technologies and subsequent move toward continuous processing (CP) for clinical and commercial manufacture have created a great need to evaluate the risks, challenges, opportunities and strategies for implementing these types of technologies into modern-day bioprocessing. Cambridge Healthtech Institute’s Fourth Annual Single-Use Technologies and Continuous Processing conference once again gathers technology and equipment providers, end users, and regulators to discuss innovative approaches to current challenges, update companies on the trends in technology, share case studies on successful implementation, and ultimately identify how to derive as much value as possible from these technological advances.

Preliminary Agenda


CONTINUOUS PROCESSING: ADVANCES, IMPLEMENTATION
AND ENABLING TECHNOLOGIES

Challenges and Limitations of Continuous Processing and Use of Disposables

Berthold Boedeker, Ph.D., Chief Scientist, Global Biologics Development, Bayer Pharma AG

Flexible Facility Designs Complementing Continuous Processing

Dennis Powers, Director, Sales Engineering, G-CON Manufacturing


STANDARDS AND RECOMMENDATIONS
FOR SINGLE-USE EQUIPMENT AND PROCESS

Wide-Scale Adoption of Single-Use Systems – What Are the Challenges Ahead from the Regulators’, Suppliers’ and End Users’ Perspectives?

Jerold Martin, MSc, Chairman, BPSA BoD and Technology (E+L) Committee

A View from the Regulators — The Modernization of Pharmaceutical Manufacturing

Desmond G. Hunt, Ph.D., Senior Scientific Liaison, U.S. Pharmacopeial Convention (USP)

Talk Title to be Announced

Dennis Jenke, Ph.D., Baxter Distinguished Scientist, Technology Resources, Baxter Healthcare Corp.

Update of Benchmarking Survey of RA Models

Ken Wong, Deputy Director, MTech/AP&T - Extractables & Leachables, Sanofi Pasteur


RISK MITIGATION STRATEGIES FOR SINGLE-USE TECHNOLOGIES

Implementation Strategies and Challenges for Single-Use at Clinical to Commercial Scale: Integrity Testing, Material Qualification, Handling Risks

Adam Goldstein, MSc, Principal Scientist, Global Technology, Roche/Genentech

Update on Vendor Change Notifications for Single-Use Systems

Jeff Carter, Ph.D., Manager, Product Strategy, ReadyToProcess Product Line, GE Healthcare




For questions about the meeting, please contact:

Kip Harry
Conference Director
Cambridge Healthtech Institute
Phone: 781-972-5454
Email: kharry@healthtech.com

For partnering & sponsorship information, please contact:

Companies A-K
Jason Gerardi
Manager, Business Development
Cambridge Healthtech Institute
Phone: 781-972-5452
Fax: 781-972-5470
Email: jgerardi@healthtech.com

Companies L-Z
Carol Dinerstein
Director, Business Development
Cambridge Healthtech Institute
Phone: 781-972-5471
Fax: 781-972-5470
Email: dinerstein@healthtech.com